438574-22-2

Upstream product

• 22539-93-1 3-benzyloxypropanone 
• 351004-29-0 tert-butyl 2,2,2-trichloroethanecarboximidate 
• 191110-59-5 3-benzyloxy-2-[N-(tert-butoxycarbonyl)amino]-2-methylpropanoic acid 
• 191110-57-3 5-((benzyloxy)methyl)-5-methylimidazolidine-2,4-dione 
• 191110-58-4 2-Amino-3-benzyloxy-2-methyl-propionic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 98946-18-0 tert-Butyl 2,2,2-trichloroacetimidate 

Downstream Products

• 438574-27-7 3-hydroxy-2-(N-[bis(4-methoxyphenyl)methyl]amino)-2-methylpropanoic acid tert-butyl ester 
• 438574-29-9 3-[bis(4-methoxyphenyl)methyl]-4-methyl-1,2,3-oxathiazolidine-4-carboxylic acid tert-butyl ester 2-oxide 
• 438574-31-3 3-[bis(4-methoxyphenyl)methyl]-4-methyl-1,2,3-oxathiazolidine-4-carboxylic acid tert-butyl ester 2,2-dioxide 

Relevant academic research and scientific papers

Tumor imaging compounds

The invention provides novel amino acid compounds of use in detecting and evaluating brain and body tumors. These compounds combine the advantageous properties of α-aminoisobutyric acid (AIB) analogs namely, their rapid uptake and prolonged retention in t

Radiolabeled amino acids for tumor imaging with PET: Radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid

Novel radiopharmaceuticals, including amino acids, that target neoplasms through their altered metabolic states have shown promising results in preclinical and clinical studies. Two fluorinated analogues of α-aminoisobutyric acid, 2-amino-3-fluoro-2-methy